Consulting on drug metabolism and pharmacokinetics for neurological treatments
SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK].
This study is all about helping scientists find better ways to develop new medications for brain-related conditions by giving expert advice on how drugs are processed in the body and suggesting improvements to their research plans.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | White Global Pharma Consu NIH-funded |
| Lab location | 1 site (Cranbury, United States) |
| Project ID | NIH-11059581 on NIH RePORTER |
What this research studies
This research involves providing expert consulting services to improve drug metabolism and pharmacokinetics (DMPK) for the NIH Blueprint Neurotherapeutics Network. The focus is on evaluating study protocols and data to identify challenges in drug discovery and development, and recommending strategies to overcome these challenges. The project also includes assisting in the design of pharmacokinetics studies and analyzing data to support the development of new treatments for neurological disorders.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research are individuals with neurological disorders who may be treated with new investigational drugs developed through improved pharmacokinetics.
Not a fit: Patients with conditions unrelated to neurological disorders or those not involved in drug development processes may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective drug development processes for neurological conditions, ultimately improving treatment options for patients.
How similar studies have performed: Previous research in pharmacokinetics has shown success in improving drug development processes, indicating that this approach is likely to yield beneficial outcomes.
Where this research is happening
Cranbury, United States
- White Global Pharma Consu — Cranbury, United States (Active)
Researchers
- Principal investigator: White, Ronald — White Global Pharma Consu
- Study coordinator: White, Ronald
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.